These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 27058207

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review.
    Papacocea SI, Vrinceanu D, Dumitru M, Manole F, Serboiu C, Papacocea MT.
    Int J Mol Sci; 2024 Sep 08; 25(17):. PubMed ID: 39273661
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A, Schmitz AL, Knoll A, Schneider M, Hlavac M, König R, Wirtz CR, Coburger J.
    Clin Neurol Neurosurg; 2018 Apr 08; 167():6-10. PubMed ID: 29425743
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region.
    Ayoub Z, Geara F, Najjar M, Comair Y, Khoueiry-Zgheib N, Khoueiry P, Mahfouz R, Boulos FI, Kamar FG, Andraos T, Saadeh F, Kreidieh F, Abboud M, Skaf G, Assi HI.
    Clin Neurol Neurosurg; 2019 Jul 08; 182():92-97. PubMed ID: 31108342
    [Abstract] [Full Text] [Related]

  • 27. Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients.
    Tang K, Jin Q, Yan W, Zhang W, You G, Liu Y, Jiang T.
    Med Oncol; 2012 Jun 08; 29(2):1292-6. PubMed ID: 21394635
    [Abstract] [Full Text] [Related]

  • 28. Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
    De Barros A, Attal J, Roques M, Nicolau J, Sol JC, Charni S, Cohen-Jonathan-Moyal E, Roux FE.
    Clin Neurol Neurosurg; 2020 Sep 08; 196():105972. PubMed ID: 32512407
    [Abstract] [Full Text] [Related]

  • 29. Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
    Mareike M, Franziska SB, Julia E, Daniel H, Michael S, Jörg F, Marion R.
    J Neurooncol; 2021 Jul 08; 153(3):537-545. PubMed ID: 34185258
    [Abstract] [Full Text] [Related]

  • 30. Correlation Between the Residual Tumor Volume, Extent of Tumor Resection, and O6-Methylguanine DNA Methyltransferase Status in Patients with Glioblastoma.
    Sharma M, Bellamkonda S, Mohapatra S, Meola A, Jia X, Mohammadi A, Angelov L, Barnett GH, Vogelbaum M, Ahluwalia MS.
    World Neurosurg; 2018 Aug 08; 116():e147-e161. PubMed ID: 29709748
    [Abstract] [Full Text] [Related]

  • 31. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS, Shin NY, Chang JH, Kim SH, Kim EH, Kim DW, Lee SK.
    J Neurosurg; 2014 Aug 08; 121(2):367-73. PubMed ID: 24949678
    [Abstract] [Full Text] [Related]

  • 32. Predictors of Survival in Turkish Patients with Primary Glioblastoma.
    Bilgin E, Duman BB, Altintas S, Cil T, Gezercan Y, Okten AI.
    Turk Neurosurg; 2021 Aug 08; 31(4):641-653. PubMed ID: 33759174
    [Abstract] [Full Text] [Related]

  • 33. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
    Gramatzki D, Kickingereder P, Hentschel B, Felsberg J, Herrlinger U, Schackert G, Tonn JC, Westphal M, Sabel M, Schlegel U, Wick W, Pietsch T, Reifenberger G, Loeffler M, Bendszus M, Weller M.
    Neurology; 2017 Apr 11; 88(15):1422-1430. PubMed ID: 28298550
    [Abstract] [Full Text] [Related]

  • 34. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM, Suki D, Hess K, Sawaya R.
    J Neurosurg; 2016 Apr 11; 124(4):977-88. PubMed ID: 26495941
    [Abstract] [Full Text] [Related]

  • 35. Tumor-associated alterations in white matter connectivity have prognostic significance in MGMT-unmethylated glioblastoma.
    Rammohan N, Ho A, Saxena M, Bajaj A, Kruser TJ, Horbinski C, Korutz A, Tate M, Sachdev S.
    J Neurooncol; 2022 Jul 11; 158(3):331-339. PubMed ID: 35525907
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
    Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, Ormiston L, Ancheta K, Hanna R, Miller P, Piccioni D, Ellingson BM, Buchanan C, Mischel PS, Nghiemphu PL, Green R, Wang HJ, Pope WB, Liau LM, Elashoff RM, Cloughesy TF, Yong WH, Lai A.
    Neuro Oncol; 2013 Mar 11; 15(3):370-81. PubMed ID: 23328811
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, Vogelbaum MA.
    J Neurosurg; 2014 Nov 11; 121(5):1115-23. PubMed ID: 25192475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.